Targeting mTOR for the treatment of B cell malignancies

British Journal of Clinical Pharmacology
Jong-Hoon Scott LeeDavid A Fruman

Abstract

Mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that functions as a key regulator of cell growth, division and survival. Many haematologic malignancies exhibit elevated or aberrant mTOR activation, supporting the launch of numerous clinical trials aimed at evaluating the potential of single agent mTOR-targeted therapies. While promising early clinical data using allosteric mTOR inhibitors (rapamycin and its derivatives, rapalogs) have suggested activity in a subset of haematologic malignancies, these agents have shown limited efficacy in most contexts. Whether the efficacy of these partial mTOR inhibitors might be enhanced by more complete target inhibition is being actively addressed with second generation ATP-competitive mTOR kinase inhibitors (TOR-KIs), which have only recently entered clinical trials. However, emerging preclinical data suggest that despite their biochemical advantage over rapalogs, TOR-KIs may retain a primarily cytostatic response. Rather, combinations of mTOR inhibition with other targeted therapies have demonstrated promising efficacy in several preclinical models. This review investigates the current status of rapalogs and TOR-KIs in B cell malignancies, with an emphasis on emerging ...Continue Reading

References

Sep 25, 1997·Trends in Biochemical Sciences·B M Marte, J Downward
Jun 11, 1999·Genes & Development·A C GingrasN Sonenberg
Apr 18, 2002·Leukemia·J B Almond, G M Cohen
Oct 29, 2002·Nature Genetics·Oksana R BereshchenkoRiccardo Dalla-Favera
Jun 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lan V PhamRichard J Ford
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Valerie I BrownStephan A Grupp
Aug 18, 2004·Genes & Development·Nissim Hay, Nahum Sonenberg
Oct 7, 2004·Nature Cell Biology·Estela JacintoMichael N Hall
Dec 23, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andre GoyAlma M Rodriguez
Dec 23, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorAndrew D Zelenetz
Jan 22, 2005·Experimental Hematology·Sakura SakajiriH Phillip Koeffler
Feb 5, 2005·Trends in Biochemical Sciences·Lars P van der Heide, Marten P Smidt
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
May 10, 2005·Blood·Raffaella AvellinoMaria Fiammetta Romano
Jun 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigScott H Kaufmann
Aug 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hitomi MatsuzakiAkiyoshi Fukamizu
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian GulmannAndrew L Feldman
Oct 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yan ZhaoQiang Yu
Dec 13, 2005·Nature Reviews. Cancer·Andreas G BaderPeter K Vogt
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen
Apr 1, 2006·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Luca Paoluzzi, Owen A O'Connor
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Jun 10, 2006·The EMBO Journal·David ShahbazianNahum Sonenberg
Aug 17, 2006·Blood·Ludivine LeseuxChristine Bezombes
Sep 27, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard I FisherAndré Goy
Oct 17, 2006·Oncogene·Y MamaneN Sonenberg

❮ Previous
Next ❯

Citations

Dec 17, 2016·Scientific Reports·Alexandra KatigbakJerry Pelletier
Feb 18, 2017·Cell Death and Differentiation·Beatrice TassoneEnzo Calautti
Mar 16, 2019·Immunological Reviews·Coraline MlynarczykAri Melnick
Apr 21, 2019·Cytopathology : Official Journal of the British Society for Clinical Cytology·Immacolata CozzolinoPio Zeppa
Dec 20, 2018·Frontiers in Oncology·Jean-Ehrland Ricci, Johanna Chiche
Feb 24, 2019·Cells·Carolina SimioniLuca M Neri
Jul 16, 2020·Cancers·Antonio Giovanni SolimandoDomenico Ribatti
Jun 29, 2018·International Journal of Molecular Sciences·Camilla EvangelistiAlberto M Martelli
Jun 2, 2017·Molecular Cancer Therapeutics·Thanh-Trang T VoDavid A Fruman
Dec 16, 2020·British Journal of Cancer·Lee-Or HerzogDavid A Fruman
Jun 9, 2021·Expert Opinion on Therapeutic Patents·Han-Yue QiuMin Zhang
Nov 6, 2021·Scientific Reports·Thanh-Trang VoDavid A Fruman
Oct 15, 2021·European Journal of Immunology·Clarissa Braun, Thomas Weichhart

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo
Expert Opinion on Therapeutic Targets
Xuerong Wang, Shi-Yong Sun
© 2021 Meta ULC. All rights reserved